|
Letter from the CEO
Every so often an opportunity to work on
something truly special comes along.
Uterine fibroids are a major area of concern for the millions of
women suffering with their symptoms. The medical device industry has
failed to provide these women with what they are demanding; a safe,
effective treatment for uterine fibroids that lets them keep their
uterus while eliminating all of their fibroids and their symptoms.
We founded HALT Medical four years ago with the goal of creating
just such a treatment. We set out to develop a surgical procedure
and laparoscopic surgical device that gynecologists could use to
safely remove uterine fibroids and the often debilitating symptoms
they cause.
The clinical results we have enjoyed in our international studies to
date have been everything we had hoped for and more, and we have
recently received our CE Mark for treating uterine fibroids in the
European Union.
Halt Medical is currently focused on completing a similar study in
the US. If you are interested in learning more about the Halt
Fibroid study, you’ll find the information you need in this website.
If you have any questions that we haven’t answered, please give us a
call. With your help, we will soon be able to empower gynecologists
to provide women with the kind of treatment that up till now has
eluded them.
Every so often an opportunity to work on something truly special
comes along...

Jeffrey M. Cohen
|
|